John Overdeck’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-193,034
| Closed | -$873K | – | 4640 |
|
|
2025
Q4 | $873K | Buy |
193,034
+119,402
| +162% | +$612K | ﹤0.01% | 3019 |
|
|
2025
Q3 | $397K | Hold |
73,632
| – | – | ﹤0.01% | 3095 |
|
|
2025
Q2 | $400K | Sell |
73,632
-138
| -0.2% | -$547 | ﹤0.01% | 2675 |
|
|
2025
Q1 | $204K | Sell |
73,770
-40,915
| -36% | -$142K | ﹤0.01% | 2848 |
|
|
2024
Q4 | $391K | Buy |
+114,685
| New | +$331K | ﹤0.01% | 2644 |
|
|
2022
Q4 | – | Sell |
-25,789
| Closed | -$203K | – | 2846 |
|
|
2022
Q3 | $203K | Buy |
+25,789
| New | +$301K | ﹤0.01% | 2099 |
|
|
2022
Q1 | – | Sell |
-26,645
| Closed | -$914K | – | 3017 |
|
|
2021
Q4 | $914K | Buy |
+26,645
| New | +$1.07M | ﹤0.01% | 2642 |
|
|
2020
Q4 | – | Sell |
-8,621
| Closed | -$401K | – | 3402 |
|
|
2020
Q3 | $401K | Buy |
+8,621
| New | +$481K | ﹤0.01% | 2394 |
|
John Overdeck's CVAC Position: Q1 2026 in Review
John Overdeck sold out of CureVac (CVAC) in Q1 2026, closing a stake of 193,034 shares — an estimated $873K sold.
John Overdeck first reported a position in CVAC in Q3 2020 and held it in 8 quarters. The position peaked at $914K in Q4 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- John Overdeck reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- John Overdeck sold 193,034 CureVac shares in Q1 2026, an estimated $873K.
- John Overdeck first reported a position in CureVac in Q3 2020 and held it in 8 quarters.
- John Overdeck's CureVac position peaked at $914K in Q4 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.